Dopamine agonist therapy or hyperprolactinemia

被引：16
|
作者：
Bankowski, BJ [1 ]
Zacur, HA [1 ]
机构：
[1] Johns Hopkins Med Inst, Div Reprod Endocrinol & Infertil, Dept Gynecol & Obstet, Baltimore, MD 21210 USA
来源：
CLINICAL OBSTETRICS AND GYNECOLOGY | 2003年 / 46卷 / 02期
关键词：
D O I：
10.1097/00003081-200306000-00013
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：349 / 362
页数：14
相关论文
共 50 条
  • [1] Dopamine agonist therapy in hyperprolactinemia
    Webster, J
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 1999, 44 (12) : 1105 - 1110
  • [2] Dopamine agonist therapy for hyperprolactinemia and associated reproductive symptoms
    Zacur, HA
    Hutchison, S
    Hickman, TN
    [J]. ENDOCRINOLOGIST, 1997, 7 (05): : 399 - 404
  • [3] Recurrence of Hyperprolactinemia after Discontinuation of Dopamine Agonist Therapy in Patients with Prolactinomas
    Ballarino, Carolina
    Diez, Sabrina
    Mallea Gil, Susana
    Salazar, Mariana
    Stalldecker, Graciela
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [4] Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study
    Maya Barake
    A. Eden Evins
    Luke Stoeckel
    Gladys N. Pachas
    Lisa B. Nachtigall
    Karen K. Miller
    Beverly M. K. Biller
    Nicholas A. Tritos
    Anne Klibanski
    [J]. Pituitary, 2014, 17 : 150 - 156
  • [5] Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study
    Barake, Maya
    Evins, A. Eden
    Stoeckel, Luke
    Pachas, Gladys N.
    Nachtigall, Lisa B.
    Miller, Karen K.
    Biller, Beverly M. K.
    Tritos, Nicholas A.
    Klibanski, Anne
    [J]. PITUITARY, 2014, 17 (02) : 150 - 156
  • [6] Dopamine agonist withdrawal in hyperprolactinemia: when and how
    Salvatori, Roberto
    [J]. ENDOCRINE, 2018, 59 (01) : 4 - 6
  • [7] Dopamine agonist withdrawal in hyperprolactinemia: when and how
    Roberto Salvatori
    [J]. Endocrine, 2018, 59 : 4 - 6
  • [8] Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children
    Cohen, LG
    Biederman, J
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (04) : 435 - 440
  • [9] Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia
    Gomez, Raul
    Abad, Antonio
    Delgado, Francisco
    Tamarit, Silvia
    Simon, Carlos
    Pellicer, Antonio
    [J]. FERTILITY AND STERILITY, 2011, 95 (03) : 882 - U64
  • [10] Adjunctive treatment with a dopamine partial agonist, aripiprazole for antipsychotic induced hyperprolactinemia
    Shim, J. C.
    Kelly, D. L.
    Jung, D. U.
    Seo, Y. S.
    Kim, Y. H.
    Conley, R. R.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S405 - S406
12345